Hospital in Gurugram launches India's first centre of excellence for Myeloma & Lymphoma, advancing precision blood cancer care

In a significant development, a private hospital in Gurugram has launched India's first Centre of Excellence for Myeloma & Lymphoma, aiming to provide highly specialized and patient-centric care to patients suffering from these diseases. The centre is built around the philosophy of 'One Disease. One Doctor. One Focus', ensuring that each patient receives personalized attention and treatment from a dedicated team of experts. This approach is expected to significantly improve treatment outcomes and quality of life for patients. The centre will also focus on research and development, with the goal of identifying new and innovative treatments for myeloma and lymphoma. With the launch of this centre, patients in India will have access to world-class treatment and care for these diseases, reducing the need for them to travel abroad for treatment. The centre will also provide training and education to healthcare professionals, helping to raise awareness and improve the overall standard of care for blood cancer patients in the country. Furthermore, the centre's research-driven approach will enable it to stay at the forefront of the latest developments and advancements in the field, ensuring that patients receive the most effective and up-to-date treatments available. The centre's team of experts will work closely with patients and their families to develop personalized treatment plans, taking into account their unique needs and circumstances. This holistic approach will not only improve treatment outcomes but also provide emotional and psychological support to patients and their loved ones. The launch of the centre is a major milestone in the fight against blood cancer in India, and is expected to have a significant impact on the lives of patients and their families.